Ryanodine receptors: physiological function and deregulation in Alzheimer disease

[1]  Grace E. Stutzmann,et al.  Calcium channelopathies and Alzheimer's disease: insight into therapeutic success and failures. , 2014, European journal of pharmacology.

[2]  L. Good,et al.  The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease , 2014, Channels.

[3]  I. Bezprozvanny,et al.  Can the Calcium Hypothesis Explain Synaptic Loss in Alzheimer's Disease? , 2013, Neurodegenerative Diseases.

[4]  Jie Shen,et al.  Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons , 2013, Proceedings of the National Academy of Sciences.

[5]  C. Hidalgo,et al.  Amyloid β-peptide oligomers, ryanodine receptor-mediated Ca2+ release, and Wnt-5a/Ca2+ signaling: opposing roles in neuronal mitochondrial dynamics? , 2013, Front. Cell. Neurosci..

[6]  Samuel Bandara,et al.  Regulators of Calcium Homeostasis Identified by Inference of Kinetic Model Parameters from Live Single Cells Perturbed by siRNA , 2013, Science Signaling.

[7]  J. Molinuevo,et al.  A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease , 2013, Neurobiology of Aging.

[8]  I. Parker,et al.  Cytotoxicity of Intracellular Aβ42 Amyloid Oligomers Involves Ca2+ Release from the Endoplasmic Reticulum by Stimulated Production of Inositol Trisphosphate , 2013, The Journal of Neuroscience.

[9]  D. Macmillan,et al.  FK506 binding proteins: cellular regulators of intracellular Ca2+ signalling. , 2013, European journal of pharmacology.

[10]  P. Papazafiri,et al.  Downregulation of AβPP enhances both calcium content of endoplasmic reticulum and acidic stores and the dynamics of store operated calcium channel activity. , 2013, Journal of Alzheimer's disease : JAD.

[11]  J. Richardson,et al.  Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s Disease , 2012, PloS one.

[12]  K. Wada,et al.  Calcium leak through ryanodine receptor is involved in neuronal death induced by mutant huntingtin. , 2012, Biochemical and biophysical research communications.

[13]  BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer’s disease , 2012, Molecular Neurodegeneration.

[14]  T. Pozzan,et al.  Ca2+ dysregulation in neurons from transgenic mice expressing mutant presenilin 2 , 2012, Aging cell.

[15]  M. Wolfe.  Processive proteolysis by γ-secretase and the mechanism of Alzheimer’s disease , 2012, Biological chemistry.

[16]  O. Arancio,et al.  Role of Leaky Neuronal Ryanodine Receptors in Stress- Induced Cognitive Dysfunction , 2012, Cell.

[17]  F. Benfenati,et al.  Ryanodine Receptor Blockade Reduces Amyloid-β Load and Memory Impairments in Tg2576 Mouse Model of Alzheimer Disease , 2012, The Journal of Neuroscience.

[18]  H. Das,et al.  Repression of transcription of presenilin‐1 inhibits γ‐secretase independent ER Ca2+ leak that is impaired by FAD mutations , 2012, Journal of neurochemistry.

[19]  J. Molgó,et al.  Early Presynaptic and Postsynaptic Calcium Signaling Abnormalities Mask Underlying Synaptic Depression in Presymptomatic Alzheimer's Disease Mice , 2012, The Journal of Neuroscience.

[20]  B. Strooper,et al.  Response to Shilling et al. , 2012 .

[21]  J. Foskett,et al.  Reply to Bezprozvanny et al.: Response to Shilling et al. (10.1074/jbc.M111.300491) , 2012, The Journal of Biological Chemistry.

[22]  B. de Strooper,et al.  Response to Shilling et al. (10.1074/jbc.M111.300491) , 2012, The Journal of Biological Chemistry.

[23]  M. Eckenhoff,et al.  Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice , 2012, Neuroscience Letters.

[24]  D. Bennett,et al.  Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease , 2012, Neurobiology of Aging.

[25]  J. A. Dani,et al.  Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson's disease , 2012, Neurobiology of Aging.

[26]  Laura Iop,et al.  Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia , 2012, EMBO molecular medicine.

[27]  L. Blatter,et al.  Dantrolene prevents arrhythmogenic Ca2+ release in heart failure. , 2012, American journal of physiology. Heart and circulatory physiology.

[28]  D. Kang,et al.  Lack of Evidence for Presenilins as Endoplasmic Reticulum Ca2+ Leak Channels* , 2012, The Journal of Biological Chemistry.

[29]  M. Sharifzadeh,et al.  Inhibition of PKA attenuates memory deficits induced by β-amyloid (1–42), and decreases oxidative stress and NF-κB transcription factors , 2012, Behavioural Brain Research.

[30]  F. Checler,et al.  The physiology of the β‐amyloid precursor protein intracellular domain AICD , 2012, Journal of neurochemistry.

[31]  J. Richardson,et al.  Stabilizing ER Ca 2 + Channel Function as an Early Preventative Strategy for Alzheimer ’ s Disease , 2012 .

[32]  X. Chen,et al.  Dantrolene is neuroprotective in Huntington's disease transgenic mouse model , 2011, Molecular Neurodegeneration.

[33]  M. Mattson,et al.  Endoplasmic Reticulum Ca2+ Handling in Excitable Cells in Health and Disease , 2011, Pharmacological Reviews.

[34]  T. Shiomi,et al.  Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. , 2011, Cell metabolism.

[35]  S. Reiken,et al.  Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusion , 2011, Proceedings of the National Academy of Sciences.

[36]  Grace E. Stutzmann,et al.  Early calcium dysregulation in Alzheimer’s disease: setting the stage for synaptic dysfunction , 2011, Science China Life Sciences.

[37]  D. Rincon-Limas,et al.  The ER stress factor XBP1s prevents amyloid-beta neurotoxicity. , 2011, Human molecular genetics.

[38]  B. de Strooper,et al.  Mutagenesis Mapping of the Presenilin 1 Calcium Leak Conductance Pore* , 2011, The Journal of Biological Chemistry.

[39]  C. Hetz,et al.  Amyloid β-peptide oligomers stimulate RyR-mediated Ca2+ release inducing mitochondrial fragmentation in hippocampal neurons and prevent RyR-mediated dendritic spine remodeling produced by BDNF. , 2011, Antioxidants & redox signaling.

[40]  E. Blalock,et al.  Disrupting Function of FK506-Binding Protein 1b/12.6 Induces the Ca2+-Dysregulation Aging Phenotype in Hippocampal Neurons , 2011, The Journal of Neuroscience.

[41]  T. Wagenknecht,et al.  Localization of the Dantrolene-binding Sequence near the FK506-binding Protein-binding Site in the Three-dimensional Structure of the Ryanodine Receptor* , 2011, The Journal of Biological Chemistry.

[42]  M. Zoli,et al.  Ryanodine receptor‐2 upregulation and nicotine‐mediated plasticity , 2011, The EMBO journal.

[43]  Huaxi Xu,et al.  APP processing in Alzheimer's disease , 2011, Molecular Brain.

[44]  Dimitra K. Georgiou,et al.  Ryanodine receptors: structure, expression, molecular details, and function in calcium release. , 2010, Cold Spring Harbor perspectives in biology.

[45]  Ivan V. Goussakov,et al.  NMDA-Mediated Ca2+ Influx Drives Aberrant Ryanodine Receptor Activation in Dendrites of Young Alzheimer's Disease Mice , 2010, The Journal of Neuroscience.

[46]  Debashis Mukhopadhyay,et al.  AICD Overexpression in Neuro 2A Cells Regulates Expression of PTCH1 and TRPC5 , 2010, International journal of Alzheimer's disease.

[47]  L. Hui,et al.  HGF suppresses high glucose-mediated oxidative stress in mesangial cells by activation of PKG and inhibition of PKA. , 2010, Free radical biology & medicine.

[48]  B. de Strooper,et al.  Role of Presenilins in Neuronal Calcium Homeostasis , 2010, The Journal of Neuroscience.

[49]  W. Klein,et al.  Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5 , 2010, Neuron.

[50]  M. Mattson.  ER Calcium and Alzheimer’s Disease: In a State of Flux , 2010, Science Signaling.

[51]  I. Bezprozvanny,et al.  The dysregulation of intracellular calcium in Alzheimer disease. , 2010, Cell calcium.

[52]  J. Bradley,et al.  Up‐regulation of the type 3 ryanodine receptor is neuroprotective in the TgCRND8 mouse model of Alzheimer’s disease , 2010, Journal of neurochemistry.

[53]  C. Ward,et al.  Amyloid-β protein impairs Ca2+ release and contractility in skeletal muscle , 2009, Neurobiology of Aging.

[54]  I. Bezprozvanny,et al.  Familial Alzheimer's disease mutations in presenilins: effects on endoplasmic reticulum calcium homeostasis and correlation with clinical phenotypes. , 2010, Journal of Alzheimer's disease : JAD.

[55]  Thomas G. Oertner,et al.  Differential distribution of endoplasmic reticulum controls metabotropic signaling and plasticity at hippocampal synapses , 2009, Proceedings of the National Academy of Sciences.

[56]  Ivan V. Goussakov,et al.  Deviant Ryanodine Receptor-Mediated Calcium Release Resets Synaptic Homeostasis in Presymptomatic 3xTg-AD Mice , 2009, The Journal of Neuroscience.

[57]  S. Pulst,et al.  Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 2 , 2009, The Journal of Neuroscience.

[58]  T. Südhof,et al.  Presenilins are Essential for Regulating Neurotransmitter Release , 2009, Nature.

[59]  S. Currie.  Cardiac ryanodine receptor phosphorylation by CaM Kinase II: keeping the balance right. , 2009, Frontiers in bioscience.

[60]  M. Yano,et al.  Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor. , 2009, Journal of the American College of Cardiology.

[61]  T. Pozzan,et al.  Presenilin-2 dampens intracellular Ca2+ stores by increasing Ca2+ leakage and reducing Ca2+ uptake , 2009, Journal of cellular and molecular medicine.

[62]  Y. Gong,et al.  Effect of amyloid β on capacitive calcium entry in neural 2a cells , 2009, Brain Research Bulletin.

[63]  T. Miyakawa,et al.  Comprehensive Behavioral Phenotyping of Ryanodine Receptor type 3 (RyR3) Knockout Mice: Decreased Social Contact Duration in Two Social Interaction Tests , 2009, Front. Behav. Neurosci..

[64]  S. Matecki,et al.  Hypernitrosylated ryanodine receptor/calcium release channels are leaky in dystrophic muscle , 2009, Nature Medicine.

[65]  R. Nicoll,et al.  Differential trafficking of AMPA and NMDA receptors by SAP102 and PSD-95 underlies synapse development , 2008, Proceedings of the National Academy of Sciences.

[66]  X. Chen,et al.  Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 3 , 2008, The Journal of Neuroscience.

[67]  P. Koulen,et al.  The N-terminus of presenilin-2 increases single channel activity of brain ryanodine receptors through direct protein-protein interaction. , 2008, Cell calcium.

[68]  Arthur Konnerth,et al.  Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease , 2008, Science.

[69]  J. Gálvez,et al.  Ischemia Enhances Activation by Ca2+ and Redox Modification of Ryanodine Receptor Channels from Rat Brain Cortex , 2008, The Journal of Neuroscience.

[70]  Ilya Bezprozvanny,et al.  Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease , 2008, Trends in Neurosciences.

[71]  Ian Parker,et al.  SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. , 2008, The Journal of general physiology.

[72]  O. Arancio,et al.  Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. , 2008, The Journal of clinical investigation.

[73]  Brian J. Bacskai,et al.  Aβ Plaques Lead to Aberrant Regulation of Calcium Homeostasis In Vivo Resulting in Structural and Functional Disruption of Neuronal Networks , 2008, Neuron.

[74]  F. LaFerla,et al.  SERCA pump activity is physiologically regulated by presenilin and regulates amyloid β production , 2008, The Journal of cell biology.

[75]  V. Lee,et al.  Mechanism of Ca2+ Disruption in Alzheimer's Disease by Presenilin Regulation of InsP3 Receptor Channel Gating , 2008, Neuron.

[76]  F. LaFerla,et al.  Increased intraneuronal resting [Ca2+] in adult Alzheimer’s disease mice , 2008, Journal of neurochemistry.

[77]  S. Reiken,et al.  Remodeling of ryanodine receptor complex causes “leaky” channels: A molecular mechanism for decreased exercise capacity , 2008, Proceedings of the National Academy of Sciences.

[78]  J. Segura-Aguilar,et al.  Effect of the knockdown of amyloid precursor protein on intracellular calcium increases in a neuronal cell line derived from the cerebral cortex of a trisomy 16 mouse , 2008, Experimental Neurology.

[79]  P. Koulen,et al.  The cytosolic N-terminus of presenilin-1 potentiates mouse ryanodine receptor single channel activity. , 2008, The international journal of biochemistry & cell biology.

[80]  N. Arispe,et al.  The Cell-Selective Neurotoxicity of the Alzheimer's Aβ Peptide Is Determined by Surface Phosphatidylserine and Cytosolic ATP Levels. Membrane Binding Is Required for Aβ Toxicity , 2007, The Journal of Neuroscience.

[81]  G. Taglialatela,et al.  Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice , 2007, Neurobiology of Learning and Memory.

[82]  Stephan E Lehnart,et al.  Modulation of the ryanodine receptor and intracellular calcium. , 2007, Annual review of biochemistry.

[83]  B. de Strooper,et al.  Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1. , 2007, The Journal of clinical investigation.

[84]  B. Strooper.  Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease. , 2007 .

[85]  M. Wolfe.  When loss is gain: reduced presenilin proteolytic function leads to increased Aβ42/Aβ40 , 2007 .

[86]  F. LaFerla,et al.  Enhanced Ryanodine‐Mediated Calcium Release in Mutant PS1‐Expressing Alzheimer's Mouse Models , 2007, Annals of the New York Academy of Sciences.

[87]  M. Wolfe.  When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease. , 2007, EMBO reports.

[88]  D. Westaway,et al.  Amyloid-β-(1-42) Increases Ryanodine Receptor-3 Expression and Function in Neurons of TgCRND8 Mice* , 2006, Journal of Biological Chemistry.

[89]  M. Brotto,et al.  Azumolene Inhibits a Component of Store-operated Calcium Entry Coupled to the Skeletal Muscle Ryanodine Receptor* , 2006, Journal of Biological Chemistry.

[90]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[91]  B. Strooper,et al.  Presenilins Form ER Ca2+ Leak Channels, a Function Disrupted by Familial Alzheimer's Disease-Linked Mutations , 2006, Cell.

[92]  F. LaFerla,et al.  Enhanced Ryanodine Receptor Recruitment Contributes to Ca2+ Disruptions in Young, Adult, and Aged Alzheimer's Disease Mice , 2006, The Journal of Neuroscience.

[93]  N. Arispe,et al.  Early and Late Cytotoxic Effects of External Application of the Alzheimer's Aβ Result from the Initial Formation and Function of Aβ Ion Channels† , 2006 .

[94]  N. Emptage,et al.  The role of the endoplasmic reticulum Ca2+ store in the plasticity of central neurons. , 2006, Trends in pharmacological sciences.

[95]  Stephen J Redman,et al.  Spatial segregation of neuronal calcium signals encodes different forms of LTP in rat hippocampus , 2006, The Journal of physiology.

[96]  R. Bullock.  Efficacy and Safety of Memantine in Moderate-to-Severe Alzheimer Disease: The Evidence to Date , 2006, Alzheimer disease and associated disorders.

[97]  Jae Woong Lee,et al.  PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine receptor-mediated calcium release. , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[98]  N. Arispe,et al.  Early and late cytotoxic effects of external application of the Alzheimer's Abeta result from the initial formation and function of Abeta ion channels. , 2006, Biochemistry.

[99]  M. Hori,et al.  Presenilin 2 regulates the systolic function of heart by modulating Ca2+ signaling , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[100]  F. LaFerla,et al.  Enhanced caffeine‐induced Ca2+ release in the 3xTg‐AD mouse model of Alzheimer's disease , 2005, Journal of neurochemistry.

[101]  C. Oliveira,et al.  The role of calcineurin in amyloid-β-peptides-mediated cell death , 2005, Brain Research.

[102]  P. Williams,et al.  Probing a putative dantrolene-binding site on the cardiac ryanodine receptor. , 2005, The Biochemical journal.

[103]  Ian Parker,et al.  Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.

[104]  R. Tanzi,et al.  Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.

[105]  C. Oliveira,et al.  The role of calcineurin in amyloid-beta-peptides-mediated cell death. , 2005, Brain research.

[106]  M. Bear,et al.  LTP and LTD An Embarrassment of Riches , 2004, Neuron.

[107]  C. Masters,et al.  Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β‐amyloid , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[108]  C. Oliveira,et al.  Involvement of endoplasmic reticulum Ca2+ release through ryanodine and inositol 1,4,5‐triphosphate receptors in the neurotoxic effects induced by the amyloid‐β peptide , 2004, Journal of neuroscience research.

[109]  J. Lindeboom,et al.  Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment. , 2004, European journal of pharmacology.

[110]  E. Kandel,et al.  Loss of Presenilin Function Causes Impairments of Memory and Synaptic Plasticity Followed by Age-Dependent Neurodegeneration , 2004, Neuron.

[111]  Colin L. Masters,et al.  Neurodegenerative diseases and oxidative stress , 2004, Nature Reviews Drug Discovery.

[112]  B. Winblad,et al.  γ-Secretase Activity of Presenilin 1 Regulates Acetylcholine Muscarinic Receptor-mediated Signal Transduction* , 2004, Journal of Biological Chemistry.

[113]  Grace E Stutzmann,et al.  Dysregulated IP3 Signaling in Cortical Neurons of Knock-In Mice Expressing an Alzheimer's-Linked Mutation in Presenilin1 Results in Exaggerated Ca2+ Signals and Altered Membrane Excitability , 2004, The Journal of Neuroscience.

[114]  A. Schousboe,et al.  Glutamate receptor activation in cultured cerebellar granule cells increases cytosolic free Ca2+ by mobilization of cellular Ca2+ and activation of Ca2+ influx , 2004, Experimental Brain Research.

[115]  J. Ryder,et al.  Inhibition of Aβ production and APP maturation by a specific PKA inhibitor , 2003 .

[116]  M. Berridge,et al.  Calcium signalling: dynamics, homeostasis and remodelling , 2003, Nature reviews. Molecular cell biology.

[117]  T. Foster,et al.  Gene Microarrays in Hippocampal Aging: Statistical Profiling Identifies Novel Processes Correlated with Cognitive Impairment , 2003, The Journal of Neuroscience.

[118]  J. Geiger,et al.  Presence and functional significance of presynaptic ryanodine receptors , 2003, Progress in Neurobiology.

[119]  Ian Parker,et al.  Ca2+ Signaling in Mouse Cortical Neurons Studied by Two-Photon Imaging and Photoreleased Inositol Triphosphate , 2003, The Journal of Neuroscience.

[120]  G. Collingridge,et al.  Calcium stores and synaptic plasticity. , 2002, Cell calcium.

[121]  M. Berridge,et al.  The endoplasmic reticulum: a multifunctional signaling organelle. , 2002, Cell calcium.

[122]  M. Sajin,et al.  Dantrolene protects neurons against kainic acid induced apoptosis in vitro and in vivo , 2002, Journal of cellular and molecular medicine.

[123]  B. de Strooper,et al.  A physiologic signaling role for the γ-secretase-derived intracellular fragment of APP , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[124]  H. Terasaki,et al.  Effects of Dantrolene on Extracellular Glutamate Concentration and Neuronal Death in the Rat Hippocampal CA1 Region Subjected to Transient Ischemia , 2002, Anesthesiology.

[125]  B. de Strooper,et al.  A physiologic signaling role for the gamma -secretase-derived intracellular fragment of APP. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[126]  G. Meissner,et al.  Modulation of Intracellular Calcium-Release Channels by Calmodulin , 2002, The Journal of Membrane Biology.

[127]  W. Regehr,et al.  Short-term synaptic plasticity. , 2002, Annual review of physiology.

[128]  Thomas C. Südhof,et al.  A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60 , 2001, Science.

[129]  Masahiko Watanabe,et al.  Postsynaptic Modulation of AMPA Receptor-Mediated Synaptic Responses and LTP by the Type 3 Ryanodine Receptor , 2001, Molecular and Cellular Neuroscience.

[130]  C. Louis,et al.  Dantrolene Inhibition of Ryanodine Receptor Ca2+Release Channels , 2001, The Journal of Biological Chemistry.

[131]  Alan Fine,et al.  Calcium Stores in Hippocampal Synaptic Boutons Mediate Short-Term Plasticity, Store-Operated Ca2+ Entry, and Spontaneous Transmitter Release , 2001, Neuron.

[132]  T. Südhof,et al.  A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. , 2001, Science.

[133]  M. Poo,et al.  Calcium stores regulate the polarity and input specificity of synaptic modification , 2000, Nature.

[134]  A. Delacourte,et al.  Tau pathology: a marker of neurodegenerative disorders , 2000, Current opinion in neurology.

[135]  Rafael Yuste,et al.  From form to function: calcium compartmentalization in dendritic spines , 2000, Nature Neuroscience.

[136]  M. Mattson,et al.  Presenilin-1 Mutations Increase Levels of Ryanodine Receptors and Calcium Release in PC12 Cells and Cortical Neurons* , 2000, The Journal of Biological Chemistry.

[137]  R. Tanzi,et al.  Presenilin 2 Interacts with Sorcin, a Modulator of the Ryanodine Receptor* , 2000, The Journal of Biological Chemistry.

[138]  P. Hyslop,et al.  Inhibition of abeta production and APP maturation by specific PKA inhibitors , 2000, Neurobiology of Aging.

[139]  D. Alkon,et al.  Spatial learning induced changes in expression of the ryanodine type II receptor in the rat hippocampus , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[140]  F. LaFerla,et al.  Presenilin-2 Mutations Modulate Amplitude and Kinetics of Inositol 1,4,5-Trisphosphate-mediated Calcium Signals* , 1999, The Journal of Biological Chemistry.

[141]  K. Mikoshiba,et al.  Facilitation of NMDAR-Independent LTP and Spatial Learning in Mutant Mice Lacking Ryanodine Receptor Type 3 , 1999, Neuron.

[142]  J. Fastbom,et al.  Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and β-amyloid pathologies , 1999, Neuroscience.

[143]  J C Reed,et al.  Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. , 1999, Science.

[144]  T. Furuyama,et al.  The Cell Death-promoting Gene DP5, Which Interacts with the BCL2 Family, Is Induced during Neuronal Apoptosis Following Exposure to Amyloid β Protein* , 1999, The Journal of Biological Chemistry.

[145]  F. Checler,et al.  Effect of protein kinase A inhibitors on the production of Aβ40 and Aβ42 by human cells expressing normal and Alzheimer's disease‐linked mutated βAPP and presenilin 1 , 1999, British journal of pharmacology.

[146]  F. Checler,et al.  Effect of protein kinase A inhibitors on the production of Abeta40 and Abeta42 by human cells expressing normal and Alzheimer's disease-linked mutated betaAPP and presenilin 1. , 1999, British journal of pharmacology.

[147]  H. Valdivia,et al.  Modulation of intracellular Ca2+ levels in the heart by sorcin and FKBP12, two accessory proteins of ryanodine receptors. , 1998, TIPS - Trends in Pharmacological Sciences.

[148]  Sebastiano Cavallaro,et al.  Time domains of neuronal Ca2+ signaling and associative memory: steps through a calexcitin, ryanodine receptor, K+ channel cascade , 1998, Trends in Neurosciences.

[149]  F. Checler,et al.  Post-transcriptional Contribution of a cAMP-dependent Pathway to the Formation of α- and β/γ-Secretases-Derived Products of βAPP Maturation in Human Cells Expressing Wild-type and Swedish Mutated βAPP , 1998, Molecular medicine.

[150]  Peter Lipp,et al.  Calcium - a life and death signal , 1998, Nature.

[151]  D. Alkon,et al.  Calcium Responses in Fibroblasts from Asymptomatic Members of Alzheimer's Disease Families , 1998, Neurobiology of Disease.

[152]  M. Segal,et al.  Fast confocal imaging of calcium released from stores in dendritic spines , 1998, The European journal of neuroscience.

[153]  Roger Y. Tsien,et al.  Cell-permeant caged InsP3 ester shows that Ca2+ spike frequency can optimize gene expression , 1998, Nature.

[154]  J. Meldolesi,et al.  The endoplasmic reticulum Ca2+ store: a view from the lumen. , 1998, Trends in biochemical sciences.

[155]  D. Alkon,et al.  Abnormalities in Alzheimer’s Disease Fibroblasts Bearing the APP670/671 Mutation , 1997, Neurobiology of Aging.

[156]  J. Mickelson,et al.  Dantrolene Inhibition of Sarcoplasmic Reticulum Ca2+Release by Direct and Specific Action at Skeletal Muscle Ryanodine Receptors* , 1997, The Journal of Biological Chemistry.

[157]  D. Selkoe,et al.  Caffeine Stimulates Amyloid β‐Peptide Release from β‐Amyloid Precursor Protein‐Transfected HEK293 Cells , 1997 .

[158]  G. Lamb,et al.  Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia. , 1997, Biophysical journal.

[159]  D. Maclennan,et al.  Single-channel properties of the recombinant skeletal muscle Ca2+ release channel (ryanodine receptor). , 1997, Biophysical journal.

[160]  T. Murayama,et al.  Characterization of Type 3 Ryanodine Receptor (RyR3) of Sarcoplasmic Reticulum from Rabbit Skeletal Muscles* , 1997, The Journal of Biological Chemistry.

[161]  Yvonne M. Kobayashi,et al.  Complex Formation between Junctin, Triadin, Calsequestrin, and the Ryanodine Receptor , 1997, The Journal of Biological Chemistry.

[162]  R. Nixon,et al.  Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease , 1997, Brain Research.

[163]  M. Mattson,et al.  Alzheimer’s Presenilin Mutation Sensitizes Neural Cells to Apoptosis Induced by Trophic Factor Withdrawal and Amyloid β-Peptide: Involvement of Calcium and Oxyradicals , 1997, The Journal of Neuroscience.

[164]  A. Dulhunty,et al.  Magnesium Inhibition of Ryanodine-Receptor Calcium Channels: Evidence for Two Independent Mechanisms , 1997, The Journal of Membrane Biology.

[165]  D. Selkoe,et al.  Caffeine stimulates amyloid beta-peptide release from beta-amyloid precursor protein-transfected HEK293 cells. , 1997, Journal of neurochemistry.

[166]  Huafeng Wei,et al.  Dantrolene Is Cytoprotective in Two Models of Neuronal Cell Death , 1996, Journal of neurochemistry.

[167]  K. Kawasaki,et al.  Protein kinase inhibitor attenuates apoptotic cell death induced by amyloid β protein in culture of the rat cerebral cortex , 1996, Neuroscience Letters.

[168]  M. Mattson,et al.  Activation of K+ channels and suppression of neuronal activity by secreted β-amyloid-precursor protein , 1996, Nature.

[169]  F. Checler.  Processing of the β‐Amyloid Precursor Protein and Its Regulation in Alzheimer's Disease , 1995 .

[170]  M E Greenberg,et al.  Calcium signaling in neurons: molecular mechanisms and cellular consequences. , 1995, Science.

[171]  S. Mammarella,et al.  The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues , 1995, The Journal of cell biology.

[172]  F. Checler.  Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease. , 1995, Journal of neurochemistry.

[173]  P. Greengard,et al.  Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[174]  D. Selkoe,et al.  Calcium ionophore increases amyloid beta peptide production by cultured cells. , 1994, Biochemistry.

[175]  K. Oka,et al.  Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[176]  A. Verkhratsky,et al.  Caffeine-induced calcium release from internal stores in cultured rat sensory neurons , 1993, Neuroscience.

[177]  S. Younkin,et al.  Production of Amyloid β Protein from Normal Amyloid β‐Protein Precursor (βAPP) and the Mutated βAPPS Linked to Familial Alzheimer's Disease a , 1993 .

[178]  E. Rojas,et al.  Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[179]  S. Younkin,et al.  Production of amyloid beta protein from normal amyloid beta-protein precursor (beta APP) and the mutated beta APPS linked to familial Alzheimer's disease. , 1993, Annals of the New York Academy of Sciences.

[180]  S. B. Kater,et al.  Role of intracellular calcium in NI-35-evoked collapse of neuronal growth cones. , 1993, Science.

[181]  G. Collingridge,et al.  Thapsigargin blocks the induction of long-term potentiation in rat hippocampal slices , 1992, Neuroscience Letters.

[182]  M. Mattson,et al.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[183]  A. Schousboe,et al.  Dantrolene Prevents Glutamate Cytotoxicity and Ca2+ Release from Intracellular Stores in Cultured Cerebral Cortical Neurons , 1991, Journal of neurochemistry.

[184]  G. Tollefson.  Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia , 1990, Biological Psychiatry.

[185]  Z. Khachaturian.  Introduction and Overview , 1989, Annals of the New York Academy of Sciences.

[186]  L. Farrer,et al.  Molecular Genetics of Familial Alzheimer's Disease , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[187]  M. Dailey,et al.  Dynamics of the endoplasmic reticulum and other membranous organelles in growth cones of cultured neurons , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[188]  I. Módy,et al.  Dantrolene-Na (Dantrium) blocks induction of long-term potentiation in hippocampal slices , 1989, Neuroscience Letters.

[189]  C. Cotman,et al.  Calcium, membranes, aging, and Alzheimer's disease , 1989 .

[190]  G. Meissner,et al.  Ryanodine activation and inhibition of the Ca2+ release channel of sarcoplasmic reticulum. , 1986, The Journal of biological chemistry.

[191]  M. L. Horne,et al.  Dantrolene in Human Malignant Hyperthermia A Multicenter Study , 1982 .

[192]  M. L. Horne,et al.  Dantrolene in human malignant hyperthermia. , 1982, Anesthesiology.

[193]  R. Bickerton,et al.  1-[(5-arylfurfurylidene)amino]hydantoins. A new class of muscle relaxants. , 1967, Journal of medicinal chemistry.